Study of US-ATG-F to Prevent Chronic Graft Versus Host Disease (GVHD)

This study is currently recruiting participants. (see Contacts and Locations)
Verified November 2013 by Neovii Biotech
Sponsor:
Collaborator:
Neovii Biotech NA (formerly Fresenius Biotech North America, Inc.)
Information provided by (Responsible Party):
Neovii Biotech
ClinicalTrials.gov Identifier:
NCT01295710
First received: February 9, 2011
Last updated: November 26, 2013
Last verified: November 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: September 2015
  Estimated Primary Completion Date: June 2015 (Final data collection date for primary outcome measure)